Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

31. Oktober 2023 13:27 ET | Quelle: Lirum Therapeutics, Inc.

Lirum Therapeutics Presents Positive Data on LX-101, a Novel Clinical-Stage Targeted Therapy, Demonstrating Potent Preclinical Activity Against Pediatric Sarcomas

New York, NY, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, today...
19. Oktober 2023 08:00 ET | Quelle: Lirum Therapeutics, Inc.

Lirum Therapeutics to Present at the 2023 ThinkEquity Conference

New York, NY, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases,...
05. Juni 2023 13:20 ET | Quelle: Lirum Therapeutics, Inc.

Lirum Therapeutics Presents Data on LX-101, a Novel Clinical-Stage Targeted Therapy, Demonstrating Potent Preclinical Activity Against a Range of Pediatric Cancers

NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, today...
08. Februar 2023 15:03 ET | Quelle: Lirum Therapeutics, Inc.

Lirum Therapeutics Announces Closing of $7 Million Private Placement of Common Stock

New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (the “Company” or “Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating...

Vorherige Seite